Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Erbe, A. K., Wang, W., Carmichael, L., Kim, K., Mendonca, E. A., Song, Y., Hess, D., Reville, P. K., London, W. B., Naranjo, A., Hank, J. A., Diccianni, M. B., Reisfeld, R. A., Gillies, S. D., Matthay, K. K., Cohn, S. L., Hogarty, M. D., Maris, J. M., Park, J. R., Ozkaynak, M. F., Gilman, A. L., Yu, A. L., Sondel, P. M.
The American Association for Cancer Research (AACR)
Published 2018